March 2026 SCHD Index: What's Changing?

Hey everyone, Sarah Miller here! It’s been a minute since I’ve sat down to really dig into a specific corner of the market, but given the buzz around the Schwab U.S. Dividend Equity ETF (SCHD) and its upcoming March 2026 index reconstitution, I felt it was time for a good, old-fashioned deep dive. Think of this as us grabbing a coffee and talking shop about your portfolio. SCHD: Your Complete Guide To The March 2026 Index Reconstitution I’ve been watching the dividend ETF space for over a decade now, and SCHD has consistently been a darling for investors focused on income and growth. It’s not just about chasing the highest yield; it’s about finding quality companies that can sustainably grow their dividends. And that’s exactly what SCHD aims to do. But like any investment, understanding what goes into it and why it changes is crucial for smart financial planning. ...

March 22, 2026 · 7 min · Sarah Miller

KOID Portfolio: Humanoid Robotics Stars You Can't Miss

As Sarah Miller, Financial Analyst The Rise of the Machines: Navigating the Humanoid Robotics ETF and Top KOID Holdings Hey everyone! Sarah Miller here. It’s been a whirlwind of a few years in the markets, hasn’t it? I’ve been in financial analysis and market research for over a decade now, and honestly, the pace of innovation I’m seeing, especially in technology, is breathtaking. One area that’s been on my radar for a while, and has recently seen a surge in investor interest, is humanoid robotics. And if you’re looking at this space, you’ve likely stumbled upon the KOID ETF (Global X Robotics & Artificial Intelligence ETF). It’s a fascinating way to get exposure to this future-forward sector. ...

March 21, 2026 · 9 min · Sarah Miller

Fed Holds Rates: What's Next for Your Money?

Hey everyone, Sarah Miller here! It’s been a busy few weeks, and as always, I’ve been glued to the economic indicators and, of course, the latest FOMC meeting minutes. If you’re anything like me, you probably breathed a sigh of relief (or maybe a bit of nervous anticipation?) when the Federal Reserve decided to hold rates steady in their March meeting. But as the dust settles, one thing is crystal clear: uncertainty is the name of the game right now. ...

March 20, 2026 · 7 min · Sarah Miller

AI's Q4 Shockwave: Fundamentals Fight Back?

Hello everyone, Sarah Miller here! It’s that time of year again – Q4 2025 earnings season is just around the corner, and as always, it’s sparking some lively debates in my inbox and around the water cooler (or, let’s be honest, my home office Slack channel). This quarter, the chatter isn’t just about the usual suspects of revenue growth and profit margins. It’s a deep dive into the tectonic shifts happening in the market, specifically the age-old clash between robust, traditional company fundamentals and the undeniable, often disruptive, force of Artificial Intelligence. ...

March 19, 2026 · 8 min · Sarah Miller
Small Cap Growth: Q4 2025 Wins You Need to See

Small Cap Growth: Q4 2025 Wins You Need to See

Hey everyone, Sarah Miller here! It’s that time again – diving into the latest performance reports. Today, I want to chat about something that’s caught my eye: the AMG TimesSquare Small Cap Growth Fund Q4 2025 Performance Insights. As a financial analyst who’s spent over a decade dissecting market trends and investment strategies, I always find these end-of-year reviews fascinating. They’re not just numbers; they’re stories about how companies are navigating the ever-changing economic landscape. ...

March 18, 2026 · 7 min · Sarah Miller

EMANATE Trial: Rhythm Pharma Shares Breakthrough Phase 3 Insights

Hello everyone, Sarah Miller here! It’s been a busy week in the markets, and as always, I’ve been digging into the latest data, especially when it comes to companies making waves in the biotech space. Today, I want to chat about Rhythm Pharmaceuticals, Inc. (RYTM) and their recent discussion around the topline results and insights from their Phase 3 EMANATE trial. As someone who’s spent over a decade in financial analysis and market research, understanding the nuances of clinical trial data is crucial for spotting potential investment opportunities. ...

March 17, 2026 · 7 min · Sarah Miller
CPP Investments: Capturing Canada's Global Financial Footprint.

CPP Investments: Capturing Canada's Global Financial Footprint.

As Sarah Miller, Financial Analyst Canada Pension Fund’s Big Asia Play: What it Means for Your Investments Hey everyone, Sarah here! I’ve been diving deep into the financial news cycle, and a story popped up that really caught my eye: Canada Pension Plan Investment Board (CPP Investments) is looking to sell about $1.5 billion of its private equity assets in Asia. Now, I know what you might be thinking – “Sarah, what does a massive Canadian pension fund selling off Asian private equity have to do with my personal finance or my investment strategies?” That’s a fair question! But trust me, when a player of this magnitude makes a move like this, it sends ripples through the global markets, and understanding those ripples is key to smart financial planning and solidifying your retirement planning. I’ve been watching trends in institutional investing for over a decade, and these large-scale divestments are often telling indicators of broader market sentiment. ...

March 16, 2026 · 8 min · Sarah Miller
Prabowo's Lens: Indonesia's Future Through Dimas Ardian's Eye

Prabowo's Lens: Indonesia's Future Through Dimas Ardian's Eye

Hello everyone, Sarah Miller here! It’s been a busy few weeks keeping my finger on the pulse of global markets, and today I want to dive into something that’s been buzzing around the financial world, particularly concerning Indonesia: the recent statements by Prabowo Subianto regarding the country’s budget deficit. Prabowo and the Deficit Tightrope: A Financial Analyst’s Perspective You might have seen the headlines – “Prabowo Open to Breach Indonesia Deficit Cap Only During Crisis.” As someone who’s spent over a decade immersed in financial analysis and market research, I’ve learned that these kinds of statements, especially from political leaders, can be a bellwether for economic sentiment and, importantly, investment opportunities. Let’s break down what this means, not just for Indonesia, but for us as investors. ...

March 15, 2026 · 7 min · Sarah Miller
Kyivstar's Q4 2025: Unpacking the Latest Financial Report

Kyivstar's Q4 2025: Unpacking the Latest Financial Report

Kyivstar Group Q4 2025: What It Means for Your Portfolio Hey everyone, Sarah Miller here! It’s that time of year again – earnings season. I’ve spent over a decade poring over financial statements and digging into market trends, and honestly, it never gets old. The Kyivstar Group Ltd. (KYIV) Q4 2025 earnings call transcript landed on my desk recently, and as someone who keeps a close eye on the telecommunications sector, I wanted to share my thoughts with you all. Think of this as a chat over coffee, where I break down what the numbers mean and how it might affect your personal finance journey. ...

March 14, 2026 · 7 min · Sarah Miller
Dollar Surges as Asia Cedes Ground 3/13/2026

Dollar Surges as Asia Cedes Ground 3/13/2026

Hey everyone, Sarah Miller here! It’s Friday, March 13th, 2026, and I’m bringing you “The Asia Trade” – your weekly dose of what’s moving the markets and how we can navigate it all. Navigating Turbulent Seas: Asian Stocks Dip Amidst US-Iran Tensions Alright, let’s dive right into it. The big headline today is that Asian stocks are trading lower. Why? Well, the news wires are buzzing with ongoing tensions between the US and Iran. It’s a situation that, frankly, keeps me up at night sometimes, especially when I’m crunching numbers for clients’ financial planning. It’s that geopolitical uncertainty that can really throw a wrench into even the most carefully crafted investing strategies. ...

March 13, 2026 · 8 min · Sarah Miller